BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Biotech Bay

  Aimmune Therapeutics Announces Data on Terminology Used with Oral Immunotherapy Were Presented at EAACI 2018

  Aimmune Therapeutics, Inc. announced that data on terminology used with oral immunotherapy were presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2018 in Munich.

  May 29, 2018

   · 

  6 min read
• Genetown

  KalVista Pharmaceuticals Presents Data at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2018

  KalVista Pharmaceuticals, Inc. announced data from a poster presentation at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2018 in Munich, Germany.

  May 29, 2018

   · 

  4 min read
• Policy

  Stallergenes Greer plc: Two New Real-World Evidence Studies Show Long-Term Benefits of Sublingual Allergy Immunotherapy

  Stallergenes Greer announced positive results from two real-world evidence studies regarding the use of allergy immunotherapy (AIT) compared to the use of only symptomatic treatments to treat patients with respiratory allergies.

  May 29, 2018

   · 

  11 min read
• BioMidwest

  Health Catalyst One of Inc. Magazine’s Best Workplaces 2018

  Health Catalys has been named one of Inc. magazine’s Best Workplaces for 2018.

  May 29, 2018

   · 

  2 min read
• Breakthrough hydrolysis technology transforms animal by-products and food waste into organic fertilizer and green energy.

  An innovative Canadian technology targeting global markets has successfully completed commercial scale processing of livestock carcass by-products into fertilizers at the Lethbridge Biogas biorefining plant.

  May 29, 2018

   · 

  2 min read
• BioMidwest

  AbbVie to Present at the Goldman Sachs 39th Annual Global Healthcare Conference

  AbbVie will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, 2018.

  May 29, 2018

   · 

  1 min read
• FDA

  U.S. FDA Grants Priority Review to Astellas’ New Drug Application for Gilteritinib for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)

  FLT3 mutations impact approximately 30 percent of AML patients and are often associated with poor survival outcomes.

  May 29, 2018

   · 

  6 min read
• Drug Development

  Atox Bio Announces Enrollment of First Patient in Phase 2 Study of Acute Kidney Injury (AKI)

  Atox Bio [http://www.atoxbio.com ], today announced that the first patient has been enrolled in the Phase 2 REAKT (Reltecimod E fficacy for Acute Kidney Injury T rial) study.

  May 29, 2018

   · 

  3 min read
• Merchavia Reports Positive Results in a Breakthrough Trial for Early Prostate Cancer Diagnosis

  Merchavia Holdings and Investments reports positive results from a successful trial which was conducted Cleveland Clinic.

  May 29, 2018

   · 

  3 min read
• Policy

  Volumes Achieved as Haiti’s ‘Change Caravan’ Marks Its First Year

  In the one year since Haiti’s President Jovenel Moïse launched his flagship ‘Change Caravan’ initiative, the country has experienced significant improvements across several areas.

  May 29, 2018

   · 

  3 min read